{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:05:00Z","timestamp":1791867900416,"version":"4.3.4"},"reference-count":46,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHMRC\/National Heart Foundation Postgraduate Scholarship"},{"DOI":"10.13039\/501100001232","name":"RACP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Heart Foundation Scholarship"},{"name":"Victorian Government\u2019s Operational Infrastructure Scheme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio (ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual variability of PAC and ARR using plasma renin activity in the context of usual antihypertensive therapy has been described, but there is no data on ARR variability calculated using direct renin concentration (DRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the intra-individual variability of PAC, DRC, and ARR in the absence of interfering medications in patients with and without PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Hypertensive patients referred for investigation of PA, with at least 2 ARR measurements while off interfering medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Endocrine hypertension service of a tertiary center, from May 2017 to July 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>PAC, DRC, and ARR variability was calculated as coefficient of variation (CV) and percent difference (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis of 223 patients (55% female, median age 52\u2005years), including 162 with confirmed PA, demonstrated high variability with a sample CV of 22-25% in the PAC and sample CV of 41% to 42% in the DRC and ARR in both the PA and non-PA groups. The degree of variability was substantially higher than the assays\u2019 analytical CV. Sixty-two patients (38%) with PA had at least one ARR below 70\u2005pmol\/L:mU\/L (2.4\u2005ng\/dL:mU\/L), a cut-off for first-line screening of PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant intra-individual variability in PAC, DRC, and hence ARR occurs in a large proportion of patients being investigated for PA. These findings support the need for at least 2 ARR before PA is excluded or further investigated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgac568","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T16:15:35Z","timestamp":1664554535000},"page":"33-41","source":"Crossref","is-referenced-by-count":62,"title":["Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-032X","authenticated-orcid":false,"given":"Elisabeth","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, Victoria, 3168 , Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0295-4575","authenticated-orcid":false,"given":"Stella May","family":"Gwini","sequence":"additional","affiliation":[{"name":"University Hospital Geelong, Barwon Health , Geelong, Victoria , Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Libianto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, Victoria, 3168 , Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research , Clayton, Victoria , Australia"},{"name":"Department of Medicine, Monash University , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Weng","family":"Choy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Northern Health , Epping, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong X","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University , Clayton, Victoria , Australia"},{"name":"Monash Health Pathology, Monash Health , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, Victoria, 3168 , Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C G","family":"Doery","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University , Clayton, Victoria , Australia"},{"name":"Monash Health Pathology, Monash Health , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-2072","authenticated-orcid":false,"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, Victoria, 3168 , Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Monash Health , Clayton, Victoria, 3168 , Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research , Clayton, Victoria , Australia"},{"name":"Department of Medicine, Monash University , Clayton, Victoria , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"5","key":"2023011917153006600_dgac568-B1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023011917153006600_dgac568-B2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"2023011917153006600_dgac568-B3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1373\/clinchem.2015.242990","article-title":"A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management","volume":"61","author":"Raizman","year":"2015","journal-title":"Clin Chem"},{"issue":"18","key":"2023011917153006600_dgac568-B4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","article-title":"The diagnosis of primary aldosteronism and separation of two major subtypes","volume":"153","author":"Weinberger","year":"1993","journal-title":"Arch Intern Med"},{"issue":"5","key":"2023011917153006600_dgac568-B5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2023011917153006600_dgac568-B6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"2023011917153006600_dgac568-B7","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023011917153006600_dgac568-B8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jch.14173","article-title":"The effect of medication on the aldosterone-to-renin ratio. A critical review of the literature","volume":"23","author":"Alnazer","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"3","key":"2023011917153006600_dgac568-B9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cen.12882","article-title":"\u03b2-Blocker withdrawal is preferable for accurate interpretation of the aldosterone\u2013renin ratio in chronically treated hypertension","volume":"84","author":"Browne","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023011917153006600_dgac568-B10","first-page":"1","article-title":"New advances in the diagnosis of primary aldosteronism","volume":"6","author":"Shen","year":"2020","journal-title":"Chronic Dis Transl Med"},{"issue":"4","key":"2023011917153006600_dgac568-B11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/1470320313519487","article-title":"The ratios of aldosterone\/plasma renin activity (ARR) versus aldosterone\/direct renin concentration (ADRR)","volume":"16","author":"Glinicki","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"2023011917153006600_dgac568-B12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"7","key":"2023011917153006600_dgac568-B13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2023011917153006600_dgac568-B14","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism","volume":"31","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"issue":"11","key":"2023011917153006600_dgac568-B15","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023011917153006600_dgac568-B16","doi-asserted-by":"crossref","first-page":"dgz150","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023011917153006600_dgac568-B17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jclinepi.2007.11.003","article-title":"A practical approach to Bland-Altman plots and variation coefficients for log transformed variables","volume":"61","author":"Euser","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"5 Pt 2","key":"2023011917153006600_dgac568-B18","first-page":"F871","article-title":"Temporal pattern of renin and aldosterone secretion in men: effects of sodium balance","volume":"262","author":"Vieweg","year":"1992","journal-title":"Am J Physiol"},{"issue":"11","key":"2023011917153006600_dgac568-B19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1210\/jcem-26-11-1261","article-title":"An analysis of factors determining the circadian pattern of aldosterone excretion","volume":"26","author":"Wolfe","year":"1966","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023011917153006600_dgac568-B20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/HJH.0000000000001905","article-title":"Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism","volume":"37","author":"Kline","year":"2019","journal-title":"J Hypertens"},{"issue":"3","key":"2023011917153006600_dgac568-B21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0006-291X(86)91026-0","article-title":"Diazepam inhibits potassium-induced aldosterone secretion in adrenal glomerulosa cell","volume":"135","author":"Shibata","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2023011917153006600_dgac568-B22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/jcem-28-11-1630","article-title":"Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man","volume":"28","author":"Balikian","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023011917153006600_dgac568-B23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"34","author":"Yozamp","year":"2020","journal-title":"Am J Hypertens"},{"issue":"5","key":"2023011917153006600_dgac568-B24","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023011917153006600_dgac568-B25","doi-asserted-by":"crossref","first-page":"bvac049","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography\u2013tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1-2","key":"2023011917153006600_dgac568-B26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism\u2014careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2023011917153006600_dgac568-B27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J Hypertens"},{"issue":"6","key":"2023011917153006600_dgac568-B28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin","volume":"28","author":"Morganti","year":"2010","journal-title":"J Hypertens"},{"issue":"9","key":"2023011917153006600_dgac568-B29","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma","volume":"28","author":"Rossi","year":"2010","journal-title":"J Hypertens"},{"issue":"6","key":"2023011917153006600_dgac568-B30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem"},{"issue":"3","key":"2023011917153006600_dgac568-B31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"issue":"12","key":"2023011917153006600_dgac568-B32","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2023011917153006600_dgac568-B33","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jcem.85.9.6819","article-title":"Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage","volume":"85","author":"Oelkers","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023011917153006600_dgac568-B34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"issue":"17","key":"2023011917153006600_dgac568-B35","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.279.17.1383","article-title":"Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis","volume":"279","author":"Graudal","year":"1998","journal-title":"JAMA"},{"key":"2023011917153006600_dgac568-B36","doi-asserted-by":"crossref","first-page":"100750","DOI":"10.1016\/j.eclinm.2021.100750","article-title":"Influence of sodium intake and change in sodium intake on plasma-renin in man","volume":"33","author":"Graudal","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"Pt 3","key":"2023011917153006600_dgac568-B37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0004563215603401","article-title":"Establishment of reference intervals for aldosterone and renin in a Caucasian population using the newly developed immunodiagnostic systems specialty immunoassay automated system","volume":"53","author":"O'Shea","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"2023011917153006600_dgac568-B38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cen.14199","article-title":"Age- and sex-specific reference ranges are needed for the aldosterone\/renin ratio","volume":"93","author":"Solanki","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023011917153006600_dgac568-B39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.121.17336","article-title":"Relationship between the aldosterone-to-renin ratio and blood pressure in young adults: a longitudinal study","volume":"78","author":"Yang","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"2023011917153006600_dgac568-B40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"2023011917153006600_dgac568-B41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jhh.2008.109","article-title":"The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women","volume":"23","author":"Fommei","year":"2009","journal-title":"J Hum Hypertens"},{"issue":"2","key":"2023011917153006600_dgac568-B42","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1210\/jc.2010-1355","article-title":"Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023011917153006600_dgac568-B43","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2023011917153006600_dgac568-B44","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2023011917153006600_dgac568-B45","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2023011917153006600_dgac568-B46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac568\/46501740\/dgac568.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/1\/33\/48786833\/dgac568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/1\/33\/48786833\/dgac568.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T12:53:06Z","timestamp":1674132786000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/1\/33\/6732502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,30]]},"published-print":{"date-parts":[[2022,12,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac568","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,9,30]]}}}